|
|
|
Corporate Profile: TransMolecular
| Summary: |
TransMolecular is focused on development of novel proprietary drugs to diagnose and treat human cancers using a novel tumor targeting platform called TM601 (a 36-amino acid peptide isolated from scorpion venom).
|
| Address: |
840 Memorial Drive
Second Floor
Cambridge, MA 02139
|
| Phone
#'s: |
| Main |
(617) 995-3050 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(617) 995-3049 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
